Neuromyelitis optica spectrum disorder and rituximab: a multi-center analysis

被引：0

作者：

Novi, G. ^{[1
,2
]}

Capobianco, M. ^{[3
]}

Gallo, F. ^{[4
]}

Mataluni, G. ^{[5
,6
]}

Signori, A. ^{[4
]}

Laroni, A. ^{[1
,2
]}

Annovazzi, P. ^{[7
]}

Buttari, F. ^{[8
]}

Rossi, S. ^{[9
]}

Zuliani, L. ^{[10
]}

Sica, F. ^{[8
]}

Cocco, E. ^{[11
]}

Benedetti, L. ^{[1
,2
]}

Malucchi, S. ^{[3
]}

Frau, J. ^{[11
]}

Sperli, F. ^{[3
]}

Sormani, M. P. ^{[4
]}

机构：

[1] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy

[2] Osped Policlin San Martino, IRCCS, Genoa, Italy

[3] Univ Hosp S Luigi Gonzaga, Reg MS Ctr, Orbassano, Italy

[4] Univ Genoa, Dept Hlth Sci, Genoa, Italy

[5] Univ Tor Vergata, Clin Neurol, Dipartimento Neurosci, Rome, Italy

[6] Fdn Santa Lucia, CERC, Rome, Italy

[7] ASST Valle Olona, Multiple Sclerosis Study Ctr, Gallarate, Italy

[8] IRCCS Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy

[9] IRCCS Fdn Ist Neurol Carlo Besta, Neuroimmunol & Neuromuscular Dis Unit, Milan, Italy

[10] Osped Ca Foncello, AULSS Marca Trevigiana 2, UOC Neurol, Treviso, Italy

[11] Univ Cagliari, Osped Binaghi, Dipartimento Sci Med & Sanita Pubbl, Ctr Sclerosi Multipla, Cagliari, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P846

引用

页码：436 / 436

页数：1

共 50 条

[31] Efficacy of azathioprine, mycophenolate mofetil, and rituximab in the treatment of neuromyelitis optica spectrum disorder and analysis of prognostic factors
Zhang, Lu
Tian, Jingyuan
Dong, Xiuyu
Jia, Zhen
Sun, Yafei
Guo, Li
Tan, Guojun
Li, Bin
NEUROLOGICAL SCIENCES, 2022, 43 (04) : 2651 - 2658
[32] Epidemiology of neuromyelitis optica spectrum disorder
Asgari, N.
Lillevang, S. T.
Skejoe, H. P. B.
Falah, M.
Stenager, E.
Kyvik, K. O.
ACTA NEUROLOGICA SCANDINAVICA, 2018, 137 (06): : 626 - 627
[33] Update on neuromyelitis optica spectrum disorder
Holroyd, Kathryn B.
Manzano, Giovanna S.
Levy, Michael
CURRENT OPINION IN OPHTHALMOLOGY, 2020, 31 (06) : 462 - 468
[34] Rituximab maintenance treatment outcomes in patients with relapsing neuromyelitis optica spectrum disorder: a monocentric retrospective analysis
Xiao, Lianchen
Huang, Yanning
Sun, Hui
Gao, Sai
Huang, Dehui
Wu, Lei
ACTA NEUROLOGICA BELGICA, 2024, 124 (06) : 1847 - 1854
[35] Relapses and Serious Infections in Patients with Neuromyelitis Optica Spectrum Disorder Treated with Rituximab: A Swedish Single-Center Study
Carlsson, Olof
Jonsson, Dagur Ingi
Brundin, Lou
Iacobaeus, Ellen
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
[36] Long-term efficacy and safety of rituximab in the treatment of neuromyelitis Optica Spectrum disorder
Hayes, Michael T. G.
Adam, Robert J.
McCombe, Pamela A.
Walsh, Michael
Blum, Stefan
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2024, 10 (02)
[37] When Rituximab Falls Short: Navigating Persistent Flares in Neuromyelitis Optica Spectrum Disorder
Yung, H.
Lebovics, N.
Bhatt, A.
Raja, B.
JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 699 - 700
[38] Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab
Shidahara, K.
Hayashi, K.
Sada, K. E.
Hiramatsu, S.
Morishita, M.
Watanabe, H.
Matsumoto, Y.
Kawabata, T.
Wada, J.
LUPUS, 2018, 27 (08) : 1374 - 1377
[39] ORGANIZING PNEUMONIA: AN ETIOLOGICAL DILEMMA IN PATIENTS ON RITUXIMAB FOR TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDER
Freeman, Howard
Zuckerman, Omry
O'Sullivan, Mary
CHEST, 2024, 166 (04) : 5626A - 5627A
[40] Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial
Zahra Nikoo
Shervin Badihian
Vahid Shaygannejad
Nasrin Asgari
Fereshteh Ashtari
Journal of Neurology, 2017, 264 : 2003 - 2009

← 1 2 3 4 5 →